Akten Gel
Product Images NDC 82584-792

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Akten (NDC 82584-792). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Thea Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Akten 01)

Chemical structure of lidocaine hydrochloride anhydrous, showing the molecular arrangement including aromatic ring, amide group, ethyl groups, and hydrochloride ion.*

FDA Label Image

Principal Display Panel (1 mL Tube Carton)

Packaging label for Akten lidocaine hydrochloride ophthalmic gel 3.5%, a preservative-free sterile gel for topical ophthalmic use. The 1 mL single-patient use product is manufactured by Thea Pharma Inc. The label includes dosage warnings, storage instructions, active and inactive ingredients, and a caution about the applicator tip contamination. NDC 82584-792-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.